HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey.

AbstractOBJECTIVE:
Although in most patients induction therapy leads to complete or partial remission, relapses in patients with non-infectious mixed cryoglobulinemia vasculitis (CryoVas) remain a major problem. We aimed to identify predictors of early relapses occurring within the first 12months of treatment in such patients.
METHODS:
Patients included in the French CryoVas survey exhibiting complete/partial clinical remission and followed-up for at least 12months after induction therapy (n=145) were analyzed for predictors of early relapses.
RESULTS:
Forty out of 145 patients (28%) experienced early relapse. Relapses occurred after a median time of 9.5months after induction therapy (3-12) and involved skin (75%), joints and peripheral nerve (28% each), kidneys (25%) and gastrointestinal tract (5%). Baseline factors associated with an early relapse were purpura [HR 3.35 (1.02-10.97), P=0.046], cutaneous necrosis [HR 4.46 (1.58-12.57), P=0.005] and articular involvement [HR 2.20 (1.00-4.78), P=0.048]. The only factor negatively associated with an early relapse during follow-up was the achievement of complete immunological response [HR 0.07 (0.01-0.51), P=0.009]. The use of corticosteroids plus rituximab or cyclophosphamide tended to be associated negatively with early relapse [HR 0.43 (0.17-1.08), P=0.07].
CONCLUSION:
In patients with non-infectious CryoVas, main predictors of early relapses after initial remission are purpura, articular involvement, and cutaneous necrosis. The absence of complete immunological response during follow-up was associated with early relapse. These findings may help in adapting future treatment strategies.
AuthorsBenjamin Terrier, Isabelle Marie, David Launay, Adeline Lacraz, Pauline Belenotti, Luc de Saint-Martin, Thomas Quemeneur, Antoine Huart, Fabrice Bonnet, Guillaume Le Guenno, Jean-Emmanuel Kahn, Olivier Hinschberger, Patricia Rullier, Elisabeth Diot, Estibaliz Lazaro, Frank Bridoux, Thierry Zénone, Fabrice Carrat, Olivier Hermine, Jean-Marc Léger, Xavier Mariette, Patricia Senet, Emmanuelle Plaisier, Patrice Cacoub
JournalAutoimmunity reviews (Autoimmun Rev) Vol. 13 Issue 6 Pg. 630-4 (Jun 2014) ISSN: 1873-0183 [Electronic] Netherlands
PMID24418300 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2014 Elsevier B.V. All rights reserved.
Topics
  • Cryoglobulinemia (complications, drug therapy, immunology)
  • Follow-Up Studies
  • France
  • Humans
  • Recurrence
  • Remission Induction
  • Vasculitis (complications, diagnosis, drug therapy, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: